Molecular regulation of vascular smooth muscle cell differentiation in development and disease

被引:2762
作者
Owens, GK [1 ]
Kumar, MS [1 ]
Wamhoff, BR [1 ]
机构
[1] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA
关键词
D O I
10.1152/physrev.00041.2003
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The focus of this review is to provide an overview of the current state of knowledge of molecular mechanisms/processes that control differentiation of vascular smooth muscle cells (SMC) during normal development and maturation of the vasculature, as well as how these mechanisms/processes are altered in vascular injury or disease. A major challenge in understanding differentiation of the vascular SMC is that this cell can exhibit a wide range of different phenotypes at different stages of development, and even in adult organisms the cell is not terminally differentiated. Indeed, the SMC is capable of major changes in its phenotype in response to changes in local environmental cues including growth factors/inhibitors, mechanical influences, cell-cell and cell-matrix interactions, and various inflammatory mediators. There has been much progress in recent years to identify mechanisms that control expression of the repertoire of genes that are specific or selective for the vascular SMC and required for its differentiated function. One of the most exciting recent discoveries was the identification of the serum response factor (SRF) coactivator gene myocardin that appears to be required for expression of many SMC differentiation marker genes, and for initial differentiation of SMC during development. However, it is critical to recognize that overall control of SMC differentiation/maturation, and regulation of its responses to changing environmental cues, is extremely complex and involves the cooperative interaction of many factors and signaling pathways that are just beginning to be understood. There is also relatively recent evidence that circulating stem cell populations can give rise to smooth muscle-like cells in association with vascular injury and atherosclerotic lesion development, although the exact role and properties of these cells remain to be clearly elucidated. The goal of this review is to summarize the current state of our knowledge in this area and to attempt to identify some of the key unresolved challenges and questions that require further study.
引用
收藏
页码:767 / 801
页数:35
相关论文
共 279 条
[81]   Mechanism of inhibition of matrix metalloproteinase-9 induction by NO in vascular smooth muscle cells [J].
Gurjar, MV ;
DeLeon, J ;
Sharma, RV ;
Bhalla, RC .
JOURNAL OF APPLIED PHYSIOLOGY, 2001, 91 (03) :1380-1386
[82]   Role of reactive oxygen species in IL-1β-stimulated sustained ERK activation and MMP-9 induction [J].
Gurjar, MV ;
Deleon, J ;
Sharma, RV ;
Bhalla, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (06) :H2568-H2574
[83]   Circulating bone marrow cells can contribute to neointimal formation [J].
Han, CL ;
Campbell, GR ;
Campbell, JH .
JOURNAL OF VASCULAR RESEARCH, 2001, 38 (02) :113-119
[84]  
HANSSON GK, 1986, CLIN EXP IMMUNOL, V64, P261
[85]   Heterogeneity of smooth muscle cell populations cultured from pig coronary artery [J].
Hao, H ;
Ropraz, P ;
Verin, V ;
Camenzind, E ;
Geinoz, A ;
Pepper, MS ;
Gabbiani, G ;
Bochaton-Piallat, ML .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (07) :1093-1099
[86]   Substitution of the degenerate smooth muscle (SM) α-actin CC(A/T-rich)6GG elements with c-fos serum response elements results in increased basal expression but relaxed SM cell specificity and reduced angiotensin II inducibility [J].
Hautmann, MB ;
Madsen, CS ;
Mack, CP ;
Owens, GK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) :8398-8406
[87]  
Hautmann MB, 1997, J BIOL CHEM, V272, P10948
[88]   Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox [J].
Hautmann, MB ;
Thompson, MM ;
Swartz, EA ;
Olson, EN ;
Owens, GK .
CIRCULATION RESEARCH, 1997, 81 (04) :600-610
[89]   A SUBSTRATE OF THE CELL-ATTACHMENT SEQUENCE OF FIBRONECTIN (ARG-GLY-ASP-SER) IS SUFFICIENT TO PROMOTE TRANSITION OF ARTERIAL SMOOTH-MUSCLE CELLS FROM A CONTRACTILE TO A SYNTHETIC PHENOTYPE [J].
HEDIN, U ;
BOTTGER, BA ;
LUTHMAN, J ;
JOHANSSON, S ;
THYBERG, J .
DEVELOPMENTAL BIOLOGY, 1989, 133 (02) :489-501
[90]   PLATELET-DERIVED GROWTH-FACTOR - MECHANISM OF ACTION AND POSSIBLE INVIVO FUNCTION [J].
HELDIN, CH ;
WESTERMARK, B .
CELL REGULATION, 1990, 1 (08) :555-566